Introduction {#s1}
============

Retroviruses such as HIV have small genomes and utilize multiple strategies such as overlapping reading frames and alternative splicing, to encode their repertoire of proteins. The ∼9 kb HIV-1 genome codes for 15 proteins expressed from a set of unspliced and singly-spliced mRNAs in addition to the fully spliced messages ([@bib19]). These unspliced and singly-spliced species encode the viral structural and accessory proteins and genomic RNA needed to assemble new virions, but because they contain introns are typically retained in the nucleus for splicing. To export these RNAs to the cytoplasm, the viral protein Rev ([Figure 1A](#fig1){ref-type="fig"}), expressed from a fully spliced message, translocates into the nucleus, forms an oligomeric complex on a ∼350 nucleotide, highly structured intronic RNA element, the Rev Response Element (RRE) ([Figure 1B](#fig1){ref-type="fig"}), and directs their export through the Crm1 nuclear export pathway ([@bib18]; [@bib40]).10.7554/eLife.04120.003Figure 1.Overall organization and structure of the Rev dimer-RRE complex.(**A**) Domain organization of full-length Rev. The protein used to co-crystallize the complex contains residues 1--70 and contains the higher-order oligomerization disrupting mutations, L12S and L60R, and the surface-entropy reducing mutation, E47A. (**B**) Secondary structure of the RRE ([@bib53]; [@bib2]) with the region used for the co--crystal structure shown in red. (**C**) Sequence of IIB40 RNA with the region corresponding to the RRE shown in red. The bases are numbered according to older studies ([@bib4]) for consistency. The RNA contains a terminal UUCG tetra-loop to enhance stability and favor crystallization. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} (**D**) Overall arrangement of the Rev dimer-RNA complex: The RNA (red) is held between the first Rev molecule (blue) bound at IIB and the second Rev molecule (green) bound at the junction site. The N-terminal 11 residues and C-terminal 7 residues of Rev 1--70 are not visible in the structure. See also [Figure 1---figure supplement 2, 3](#fig1s2 fig1s3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.003](10.7554/eLife.04120.003)10.7554/eLife.04120.004Figure 1---figure supplement 1.Rev and RRE constructs.(**A**) Rev dimer structure ([@bib13]) with the higher-order oligomerization disrupting mutations, L12S and L60R shown in red. Also shown is the surface-entropy reducing mutation, E47A in blue or green. (**B**) RRE IIB40 is a derivative of the stem II three-helix junction and contains two adjacent Rev-binding sites (red). (**C**) Gel-shift assays comparing binding of ^32^P-labeled RRE-stem II or IIB40 to Rev. Free, F, monomer, M and dimer, D complexes are indicated. A doublet/smeared band is observed for the monomer complex with both RNAs and is indicative of conformational heterogeneity. (**D**) Binding curves calculated from gel-shift assays in (**C**). Apparent dissociation constants, K~d~ and Hill coefficient (n) were determined using the equation: Fraction of RNA bound = \[Rev\]^n^/(K~d~^n^ + \[Rev\]^n^) as mean ± s.d. of two replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.004](10.7554/eLife.04120.004)10.7554/eLife.04120.005Figure 1---figure supplement 2.Representative electron density maps.(**A**) The final model fit into 5.5 Å density-modified SAD electron density map (contoured at 2.0 σ). (**B**) 2F~o~ − F~c~ electron density map at 3.2 Å after molecular replacement (contoured at 2.0 σ). (**C** and **D**) Stereo view of 2F~o~ − F~c~ electron density maps located around (**C**) nucleotides that form the core structure of the junction site (contoured at 2.0 σ) (**D**) Gln51 which hydrogen bonds across the dimer interface in the RNA-bound form (contoured at 1.0 σ).**DOI:** [http://dx.doi.org/10.7554/eLife.04120.005](10.7554/eLife.04120.005)10.7554/eLife.04120.006Figure 1---figure supplement 3.Comparison of Rev monomers.Superimposition of Rev monomers corresponding to (**A**) the first Rev molecule in the unbound dimer (grey) and in the dimer-RNA complex (blue) (backbone RMSD = 1.47 Å) (**B**) the second Rev molecule in the unbound dimer (grey) and in the dimer-RNA complex (green) (backbone RMSD = 1.41 Å) (**C**) the first (blue) and second Rev (green) molecules from the dimer-RNA structure (backbone RMSD = 0.87 Å).**DOI:** [http://dx.doi.org/10.7554/eLife.04120.006](10.7554/eLife.04120.006)

Rev cooperatively assembles on the RNA using its oligomerization and RNA-binding domains to form a Rev hexamer on a shorter, but functional ∼240 nucleotide RRE ([@bib32]; [@bib57]; [@bib12], [@bib11]). This assembled RNP then presents Leu-rich nuclear export sequence (NES) peptides ([Figure 1A](#fig1){ref-type="fig"}) to interact with the host export receptor, Crm1, targeting these RRE-containing mRNAs for export ([@bib18]). In this paper we address the structural principles that govern assembly of the Rev oligomer onto the RNA and its consequences for Rev function.

The binding of Rev to the RRE is nucleated at the stem IIB hairpin, where the α-helical arginine-rich motif (ARM) of Rev ([Figure 1A,B](#fig1){ref-type="fig"}) binds in the major groove of the RNA and makes an extensive set of sequence-specific and electrostatic contacts ([@bib33]; [@bib10]; [@bib22]; [@bib27]; [@bib4]). The oligomeric complex proceeds to form by the sequential addition of Rev subunits ([@bib41]). Crystal structures of Rev oligomerization surfaces depict a central hydrophobic core that mediates interactions between Rev subunits and positions the ARMs on one side of the Rev oligomer to bind RNA and the NESs on the other side to recruit Crm1 ([@bib14]; [@bib13]), highlighting the modular nature of the Rev domains.

In addition to the modular architecture of Rev, the RNA scaffold also plays a key role in defining the organization of the complex. Biochemical studies have shown that the RRE controls the oligomeric state of Rev ([@bib11]), and a recent SAXS structure shows that the RRE adopts an 'A' shaped architecture poised to recruit Rev ([@bib17]). It remains unknown how the RNA structure is matched to the arrangement of the Rev oligomer to form the export--active complex.

One particularly fascinating question is how the individual subunits of Rev recognize the RRE. An NMR structure of a single α-helical ARM bound to the IIB RNA hairpin has been known for quite some time ([@bib4]), and a second binding site in stem IA was identified that utilizes a different surface of the helical ARM from another subunit to recognize the RNA ([@bib12]). Other binding sites in the RRE may use yet other recognition strategies that have not been defined. As a step towards understanding how individual binding sites are organized on the RRE, how their arrangement relates to the architecture of the Rev oligomer, and how the different sites are recognized by Rev, we solved the structure of a Rev dimer bound to an RRE fragment (IIB40) containing two Rev-binding sites ([@bib12]) ([Figure 1C](#fig1){ref-type="fig"}). This first high-resolution structure of a Rev-RRE complex ([Figure 1D](#fig1){ref-type="fig"}) uncovers yet another RNA recognition mode for Rev and shows how the remarkable plasticity of the Rev dimer allows it to adapt to the RNA framework.

Results {#s2}
=======

Rev dimer-RRE structure {#s2-1}
-----------------------

To better understand how Rev assembles an oligomeric complex on the RRE, we sought to determine the crystal structure of a Rev-RNA complex. Rev has a strong tendency to aggregate and fold incorrectly when not bound to RNA ([@bib13]). We circumvented these problems by making RNA complexes with Rev 1--70 harboring the oligomerization-disrupting mutations, Leu12Ser and Leu60Arg ([@bib24]), which forms a stable Rev dimer ([@bib13]), and a Glu47Ala surface-entropy reducing mutation ([@bib20]), which aided in crystallization ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

For the RNA, we utilized variants of RRE IIB40, which has the high-affinity IIB site positioned adjacent to a second site (referred to as the junction site) that mimics the stem II junction ([@bib12]) ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), and variants of a 68-nucleotide fragment comprising stems IIA, IIB and IIC. Previous biochemical studies have shown that Rev assembly initiates at stem IIB and proceeds through stem II along the length of stem I with the second Rev molecule binding at the stem II junction ([@bib34]; [@bib8]). The junction site was designed based on those studies ([@bib12]) and also on the observation that Rev binding melts a A-U base-pair in stem IIA at the junction ([@bib8]), a finding recently confirmed by SHAPE-seq experiments ([@bib2]). Gel shift assays show that Rev binds to RRE stem II and to IIB40 with comparable affinity and cooperativity ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), suggesting that IIB40 recapitulates Rev assembly at the entire stem II junction.

We attempted co-crystallizations using ∼35--40 RNA variants with altered stem lengths and tetraloop sequences and obtained well-diffracting crystals with only a single Rev dimer-IIB40 complex. We solved its structure using single-wavelength anomalous dispersion to 5.5 Å to generate models for molecular replacement at 3.2 Å, resulting in the first high-resolution view of a Rev-RRE complex ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}).10.7554/eLife.04120.007Table 1.Diffraction data collection and refinement statistics**DOI:** [http://dx.doi.org/10.7554/eLife.04120.007](10.7554/eLife.04120.007)NativeTungsten derivativeData Collection Space groupP 4~1~ 3 2P 4~1~ 2~1~ 2 Cell Dimensions a, b, c (Å)165.3, 165.3, 165.3147.22, 147.22, 199.44 α, β, γ (°)90, 90, 9090, 90, 90 Resolution (Å)45.85 − 3.2 (3.314 − 3.2)[\*](#tblfn1){ref-type="table-fn"}49.34 − 5.55 (5.75 − 5.55) Redundancy25.9 (15.9)15.2 (13.6) Completeness (%)99.72 (98.36)99.6 (96.5) *I/σI*21.56 (1.74)13 (1.8) R-meas0.138 (2)0.151 (1.52)Refinement Resolution (Å)45.85 − 3.2 (3.31 − 3.2) No. reflections342771 (20153) R~work~/R~free~19.3 (27.7)/21.1 (30.7) No. atoms RNA849 Protein862 Ligand/Ion5 Water1 B-factors RNA113.9 Protein115.3 Ion153.8 Water112.7 RMS deviations Bond lengths (Å)0.002 Bond angles (°)0.39[^1]

The Rev dimer-RRE structure depicts essential early steps in the assembly of the larger oligomeric complex. The overall architecture of the complex shows the RNA held between two Rev molecules arranged slightly asymmetrically in a V-shaped topology, with the two Rev ARMs buried in distorted major grooves positioned on opposite sides of the RNA ([Figure 1D](#fig1){ref-type="fig"}). The structures of the individual Rev monomers are nearly identical to each other and to the RNA-free form ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Comparison of the structures of the free and RNA-bound Rev dimers, described below, illustrates how the homo-oligomer adapts to bind RNA cooperatively.

The Rev dimer rearranges upon RNA binding {#s2-2}
-----------------------------------------

The Rev dimer in its RNA-free state also displays a V-shaped topology ([@bib14]; [@bib13]) but its conformation changes dramatically upon RNA binding, with the two RNA-binding helices coming much closer together in the RNA-bound complex ([Figure 2A](#fig2){ref-type="fig"}). The Rev subunit bound to the junction site forms an extensive surface with the RNA that causes the dimer interface to pivot around a single residue, Ile55 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), known to be critical for dimer integrity and function ([@bib24]; [@bib15]). This altered conformer results in complete repacking of hydrophobic residues at the dimer interface ([Figure 2B](#fig2){ref-type="fig"}), formed by residues Leu18 and Leu22 from the first helix and Ile55 and Ile59 from the second helix. Phe21, which formed a significant part of the RNA-free interface, is largely excluded.10.7554/eLife.04120.008Figure 2.Reorganization of the Rev dimer interface upon RNA binding.(**A**) Rev dimer crossing angles differ significantly between RNA-bound (top) and RNA-free (bottom) states (**B**) Packing of hydrophobic residues at the dimer interface in the RNA-bound (top) and RNA-free (bottom) states. Phe21 is largely excluded from the interface upon RNA binding and, in general, the interface is more loosely packed ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). (**C**) Gln51 hydrogen bonds across the dimer interface in the RNA-bound conformation (top) but is unable to interact in the free state (bottom). (**D**) Gel shift assays with ^32^P-labeled IIB40 RNA and Rev 1--70 dimer show that a monomeric Rev-RNA complex accumulates when Gln51 is mutated to Ala and the dimer affinity is reduced ∼30-fold ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). F corresponds to free RNA, M to the Rev monomer-RNA complex, and D to the Rev dimer-RNA complex. (**E**) Gel shift assays with the 234-nt RRE and full-length Rev, visualized using SYBR Green II staining, show reduced accumulation of dimer species and a modest loss of binding affinity with the Gln51Ala mutant ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), quantified in panel (**F**). Mu corresponds to Rev multimer-RNA complexes.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.008](10.7554/eLife.04120.008)10.7554/eLife.04120.009Figure 2---figure supplement 1.Rev interactions in the free and RNA-bound structures.(**A**) Model illustrating the 70° rotation that one subunit of the unbound Rev undergoes in order to contact the RNA at the junction site, pivoting around Ile55 (yellow) (**B**) View of the dimer interface from the top (RNA-binding side) showing that the second Rev molecule in the RNA-bound dimer is situated ∼3.2 Å further away from the first Rev subunit than in the RNA-free arrangement (**C**) Gel-shift assay using ^32^P-labeled full-length RRE (234 nucleotides) and full-length Rev illustrating the modest loss of binding affinity upon mutating Gln51 to Ala. Apparent K~d~ and n are: wild-type Rev K~d~ = 145 pM, n = 2.1; Q51A Rev K~d~ = 280 pM, n = 1.7.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.009](10.7554/eLife.04120.009)

Interestingly, the bound conformation buries less surface area at the dimer interface than the free form (1000 Å^2^ vs 1500 Å^2^) and also shows looser hydrophobic packing (the two Rev subunits are ∼3.2 Å further apart) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that this bound dimer is energetically less favorable but is compensated by the energy of RNA binding of the second Rev subunit. The weaker interface may be further compensated by hydrogen bonding between the well-conserved Gln51 residues symmetrically located between the two subunits and observed only in the bound form ([Figure 2C](#fig2){ref-type="fig"}). Thus, mutation of Gln51 to alanine results in accumulation of Rev monomer-RNA complexes and ∼30-fold reduced affinity ([Figure 2D](#fig2){ref-type="fig"}). In the context of the full-length hexameric Rev-RRE complex, the effect of the Gln51Ala mutation was modest but reproducible, showing a twofold reduction in affinity in gel shift assays using a vast excess of protein over RNA ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and reduced accumulation of dimer species in assays with stoichiometric amounts of Rev and RRE ([Figure 2E,F](#fig2){ref-type="fig"}). The modest effect of the mutation in the full-length context suggests that the Gln51 interaction may be less crucial during later stages of Rev-RRE assembly and the energetic contributions to cooperative binding may shift to other interactions, possibly coupled to further rearrangements of the Rev subunit interfaces. Alternatively, there may be multiple pathways towards cooperative assembly such that if one pathway is blocked, another may be used.

Diversity of RNA recognition by the Rev ARM {#s2-3}
-------------------------------------------

The pliability of the Rev dimer interface contributes to RNA-binding specificity by allowing the Rev subunits to orient properly to multiple binding sites arrayed on the RRE, with binding at the primary IIB RNA site nucleating assembly. Comparison of our Rev dimer-IIB40 structure to the NMR structure of a Rev ARM peptide-IIB complex ([@bib4]) shows that both the Rev arginine-rich-helix and IIB RNA site are remarkably similar in both the structures ([Figure 3A](#fig3){ref-type="fig"}), although with subtle changes to some Rev-IIB contacts ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). For example, in the NMR structure, Asn40 hydrogen bonds to a G47-A73 base pair in IIB RNA, but is in a different plane and contacts G47 and G71 from adjacent base pairs in the dimer-RNA complex ([Figure 3B](#fig3){ref-type="fig"}). Interestingly, the Asn40-IIB interaction observed in the crystal structure is similar to that seen in an NMR structure of a Rev-ARM peptide-aptamer complex ([@bib55]), suggesting that optimal Rev-RNA contacts can be selected from several favorable conformers. The subtle differences between the NMR and crystal structures likely reflect a lack of precision of the early NMR data, with no violations observed to the current structure. The similarity in Rev-IIB recognition between the NMR structure, which depicts the first step in Rev-RRE assembly, and the crystal structure, which captures the progression into cooperative assembly, reiterates the importance of preserving this highly sequence-specific interface to support a specific and productive assembly.10.7554/eLife.04120.014Figure 3.Features of Rev-RNA recognition.(**A**) The ARM peptide-IIB NMR structure (yellow) ([@bib4]) and the Rev dimer-IIB40 structure are nearly superimposable (backbone RMSD = 1.27 Å). (**B**) Contacts made by Asn40 from the first Rev subunit at the IIB RNA site are different in the Rev dimer-IIB40 (top panel) and ARM peptide-IIB complexes (bottom panel). See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. (**C**) RNA structure at the second junction site shows a G-A base-pair and A42-U43 bulge that widens the major groove to accommodate the RNA-binding helix of the second Rev subunit. See also [Figure 3---figure supplement 2, 3](#fig3s2 fig3s3){ref-type="fig"}. (**D**) Rev- RNA recognition at the three known binding sites in the RRE, shown in the three top panels as views down the helical axis of the Rev ARM at the IIB site, junction site, and stem IA. The binding residues for stem IA are inferred from alanine mutants (in red) ([@bib12]). The two bottom panels show side views from the co--crystal structure indicating that turns 1--3 of the ARM helix contact IIB while turns 2--4 contact the junction site.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.014](10.7554/eLife.04120.014)10.7554/eLife.04120.015Figure 3---figure supplement 1.Schematic representation of Rev-RNA contacts at IIB and junction sites.Schematic representation of Rev-RNA contacts at (**A**) IIB and (**B**) the junction site, generated using Nucplot ([@bib31]). Red lines indicate hydrogen bonds to the phosphate backbone or sugar, green lines indicate hydrogen bonds to the bases and blue lines indicate Van der Waals contacts.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.015](10.7554/eLife.04120.015)10.7554/eLife.04120.016Figure 3---figure supplement 2.Rev-RNA recognition at the junction site.(**A**) Model of IIB40 with a deleted AU bulge from the junction site (orange) superimposed with IIB40 showing that deleting the bulge would result in a steric clash between the RNA in A-form geometry and the second Rev subunit. (**B**) Gel-shift assay using ^32^P-labled IIB40 or bulge-deleted RNA and Rev showing an absence of the Rev-dimer-RNA complex with the bulge deleted. (**C**) Simulated annealing F~o~ − F~c~ omit map in green (contoured at 3.0 σ) around the water molecule bridging Arg44 from the second Rev subunit and the RNA junction site.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.016](10.7554/eLife.04120.016)10.7554/eLife.04120.017Figure 3---figure supplement 3.Model for RNA-directed cooperative assembly.(**A**) An A-form helix was placed near the junction site to represent the stem IIA helix not present in the crystallized RNA. The second Rev subunit from the crystal structure (green) is oriented to use its higher-order oligomerization surface to recruit a third Rev subunit (yellow) (**B**) The model generated in (**A**) was placed within the RRE SAXS envelope ([@bib17]), based on the positioning of sites from the SAXS model. (**C**) RRE secondary structure from [Figure 1B](#fig1){ref-type="fig"} placed within the envelope, indicating how other binding sites might be placed, including the IA site. Figures were generated using UCSF Chimera ([@bib39]).**DOI:** [http://dx.doi.org/10.7554/eLife.04120.017](10.7554/eLife.04120.017)

The junction site in the RNA forms a structural scaffold that helps orient the Rev subunits. It is formed by an A44-G76 base-pair, identified earlier by in vitro selection studies ([@bib3]), and a A42-U43 bulge that widens an otherwise narrow A-form major groove to accommodate the α-helix of the second Rev subunit ([Figure 3C](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Both A42 and U43 are unpaired and A42 is co-axially stacked on stem IIB, consistent with biochemical mapping experiments showing increased accessibility of these nucleotides upon Rev binding ([@bib8]; [@bib2]). Neither base is directly contacted by Rev, suggesting that their primary role is to create the junction site architecture. Consistently, deleting the bulge results in exclusively monomeric binding ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), and previous studies showed that simply introducing bulges with variable sequences juxtaposed to IIB is sufficient to mediate co-operative Rev binding ([@bib58]). Most contacts at the junction site are to the phosphate backbone with the exception of Arg 43 and Arg44 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Notably, Arg44 from both Rev subunits contacts the two binding sites on the RNA, in one case using water-mediated interactions not previously observed for RRE recognition ([Figure 3---figure supplement 1, 2](#fig3s1 fig3s2){ref-type="fig"}).

The junction site in the full-length RRE is formed by three stems (IIA, IIB, and IIC), with only IIB and IIC present in the crystallized IIB40 RNA. Stem IIA likely forms an A-form helix that merges into the junction to determine the relative placement of the remaining RRE. The second Rev subunit is positioned in the crystal structure to use its higher order oligomerization surface to recruit a third Rev subunit with its ARM oriented towards stem IIA for sequential Rev assembly. Presumably, the overall 'A'-shaped RRE topology ([@bib17]) and arrangement of binding sites dictates the positioning of newly recruited subunits ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). The specific model for Rev-RRE assembly proposed by [@bib17] portrays an initial Rev dimer bridging the RRE IIB and IA sites, but our structure and other biochemical studies of Rev-RRE assembly ([@bib8]; [@bib2]) suggest that the first Rev dimer binds to stem II before additional subunits are added. Rev dimers formed later during assembly are likely positioned to bridge the two arms of the 'A'-shaped RRE, presumably involving the IA site.

The diversity of RNA recognition by the Rev ARM is quite striking, now with examples of how Rev binds to three sites in the RRE, and yet other binding modes observed with in vitro selected nucleic acids ([@bib54]; [@bib56]; [@bib5]). The current crystal structure shows that each of the two ARMs of the Rev dimer deeply insert into a distorted RNA major groove, each burying ∼1500 Å^2^ of surface area, and that the same face of the ARM is used to contact the RNA in both cases ([Figure 3D](#fig3){ref-type="fig"}). However their helical registers differ and recognition of IIB is highly sequence-specific compared to the junction site. Furthermore, at another characterized Rev-binding site in the RRE, stem IA, yet a different binding mode seems to be utilized, with mutational studies indicating a different face of the ARM used to bind the RNA ([Figure 3D](#fig3){ref-type="fig"}) ([@bib12]).

The Rev-RNA interface at the junction site illustrates that protein contacts at individual RRE sites can be largely sequence-nonspecific if the ARM is optimally presented to the RNA, especially from the context of additional bound Rev subunits. While binding to some sites such as stem IIB or IA can show substantial specificity even in their isolated contexts, this does not seem to be the case for the remaining Rev binding sites ([@bib12]). Binding at these sites might require a more extensive RRE framework and neighboring Rev subunits and may differ from the configuration seen at the junction site, potentially adding further diversity to the recognition modes utilized by the ARM.

Contributions of RNA-binding and dimer interface residues to Rev function {#s2-4}
-------------------------------------------------------------------------

To test the functional implications of the observed interactions in the crystal structure, we monitored the effects of key mutations in Rev on RRE binding, viral RNA export, and viral replication. A previous study identified Asn40 as the most critical residue for IIB recognition, followed by Arg44, Arg38 and Arg39 ([@bib52]). In the dimer-RNA complex however, alanine substitution of Arg44, which contacts both RNA sites, was most deleterious (250-fold reduced affinity) followed by Asn40 (100-fold), Arg39 (30--50-fold), and Arg38 (10-fold) ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These mutations, as well as mutation of Gln51 which hydrogen bonds across the dimer interface, were all defective in viral RNA export and translation in Rev-RRE-dependent Gag-Pol reporter assays ([Figure 4B](#fig4){ref-type="fig"}). When engineered into HIV-1, all mutations, except Gln51, also showed attenuated viral replication in tissue culture ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). As noted above, Gln51 is important at the level of dimer formation but may be less critical in the full Rev-RRE context. RNA fluorescence in situ hybridization (FISH) of infected cells indicated that these Rev mutations caused retention of unspliced HIV-1 RNAs in the nucleus ([Figure 4D](#fig4){ref-type="fig"}), correlating with reduced Gag protein production ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Thus, key interactions observed in the Rev-RNA crystal structure have important functional roles in HIV RNA export and viral replication.10.7554/eLife.04120.010Figure 4.Role of RNA-binding and dimer interface residues in Rev function.(**A**) Representative binding curves with Rev 1--70 dimer mutations at positions observed to contact the RNA, calculated from gel shift assays using ^32^P-labeled IIB40. Apparent dissociation constants, K~d~ and Hill coefficient (n) are reported in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. (**B**) p24 production from a Rev-dependent, transiently transfected pCMV GagPol-RRE reporter assay complemented in trans with full length Rev mutants, quantified by ELISA and normalized to both Rev and GAPDH expression levels (representative western blots below show that the mutations do not affect Rev steady state expression levels or stability). Data points are mean ± s.d. of biological triplicates. (**C**) Viral replication kinetics for HIV-1~NL4-3~ containing Rev mutants, monitored by p24 release into the culture supernatant. Data points are mean ± s.d. of biological triplicates. See also [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"} (**D**) FISH of total HIV RNA or unspliced Gag RNA in the presence of the indicated Rev mutation. Nuclei were stained using DAPI (blue). Nef::Rev~3xF~ denotes infection with virus containing c-terminally 3× flag-tagged Rev in the *nef* locus. See also [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.010](10.7554/eLife.04120.010)10.7554/eLife.04120.011Figure 4---figure supplement 1.Gel-shift assays with the indicated Rev mutants.(**A**) Representative gel-shift assays using ^32^P-labeled IIB40 and the indicated Rev mutants (**B**) Apparent binding constants (K~d~) and Hill coefficients (n) calculated from fraction of total RNA bound from gel-shift assays using ^32^P-labeled IIB40 and the indicated Rev mutants. Values reported are mean ± s.d. from two replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.011](10.7554/eLife.04120.011)10.7554/eLife.04120.012Figure 4---figure supplement 2.Design of virus constructs.The endogenous *rev* locus was deleted by mutating the start codon (ATG) to ACG and introducing a termination codon at residue 23. Both mutations are silent in the overlapping *tat* open reading frame. The *nef* locus, dispensable for virus replication ex vivo, was disrupted by introducing SacII and Xba1 restriction endonuclease sites in place of the start ATG codon. Codon-optimized Rev DNA was synthesized (to avoid the introduction of direct nucleotide repeats within the HIV genome that typically results in recombination) with the endogenous Kozak sequence and flanking SacII and XbaI restriction sites to facilitate cloning within the repurposed *nef* locus.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.012](10.7554/eLife.04120.012)10.7554/eLife.04120.013Figure 4---figure supplement 3.RNA FISH and protein immunofluorescence studies.(**A**) FISH of total HIV RNA or unspliced Gag RNA showing that there is no observable phenotypic difference between *rev* in the endogenous locus and *rev* engineered into the *nef* locus. (**B**) Immunofluorescence staining for 3× flag-tagged Rev and HIV p24 capsid protein, showing that although Rev is expressed and localized in the nuclei, p24 production is attenuated to different degrees in the presence of Rev mutants. Nuclei were stained using DAPI (blue). Nef::Rev~3xF~ denotes infection with virus containing c-terminally 3× flag-tagged Rev in the *nef* locus.**DOI:** [http://dx.doi.org/10.7554/eLife.04120.013](10.7554/eLife.04120.013)

Discussion {#s3}
==========

Previous crystal structures of Rev dimers and the NMR structure of a Rev ARM-IIB complex defined key building blocks of Rev-RRE assembly, but it has been unclear how they are employed to guide cooperative RNA binding of the oligomer to assemble a fully functional complex. Our structure of the Rev-RRE complex illustrates a direct physical coupling between RNA binding and protein oligomerization, where RNA binding drastically alters the conformational state of the Rev dimer. The architecture of the RRE and positioning of individual Rev-binding sites configures the predominantly hydrophobic protein--protein interfaces to form a cooperative complex. This is reminiscent of the DNA-induced hetero-dimerization of nuclear receptors, where DNA sequence and spacing between protein-binding half-sites configures the dimer interface and dictates the choice of dimerization partners ([@bib37]; [@bib44]).

The use of non-polar residues at protein--protein interfaces has been postulated to be an attractive choice for evolutionary change as it can readily accommodate structural perturbations ([@bib30]). Structural studies of the HIV-1 capsid protein clearly illustrate the role of plasticity at interfaces to assemble complex structures such as fullerene cones ([@bib7]; [@bib42], [@bib43]). The simple modular structure of Rev, including its pliable protein--protein interface and diverse RNA-binding domain, highlights how a virus with limited coding capacity can build a large, asymmetric RNP using a small, homo-oligomeric protein to achieve remarkable structural and functional complexity.

Our structure expands the repertoire of known Rev dimer conformers to three, each with different crossing angles between the RNA-binding helices. Given the hydrophobic nature of the interfaces, other conformers are possible, especially when placed in the context of host--protein complexes. These conformers can be combined in multiple arrangements to generate oligomers with diverse architectures ([Figure 5A](#fig5){ref-type="fig"}). Since Rev likely interacts with other host proteins to transport and package viral RNAs during the virus life cycle ([@bib23]; [@bib38]), different quaternary structures of Rev may generate conformational states adapted to different host complexes at various stages of viral replication. This is highly reminiscent of the Ebola virus protein VP40, whose dimeric, hexameric, and octameric forms each have different roles in the viral life cycle ([@bib6]), again highlighting the value of adaptable homo-oligomers in small RNA viruses. Recent crystal structures of HIV Tat ([@bib51]) and Vif ([@bib21]) with host protein complexes illustrate the importance of scaffolding structures to enable viral proteins to adopt ordered, functional states. It is remarkable that for Rev, it is not the folding of a single polypeptide chain that is dictated by its scaffolding partner(s) but rather its oligomeric architecture.10.7554/eLife.04120.018Figure 5.Potential diversity of Rev oligomeric structures and functional implications.Three types of Rev--Rev interactions observed by crystallography, Rev dimers in the RNA-free ([@bib13]) or RNA-bound states (the current structure) and a Rev dimer using the higher-order oligomer interface ([@bib14]) are shown within the circle with Rev in grey and the Rev-ARMs in blue. (**A**) The higher-order oligomer interface was used to combine Rev dimers in the RNA-free state or RNA-bound state in various arrangements to generate examples of hexamers with different architectures. (**B**) Models illustrating how changes to the RRE structure (red) can alter the architecture of Rev oligomer. Such changes can alter the Rev-RRE 'jellyfish' architecture and spatial distribution of NESs, potentially changing their local effective concentration and avidity for the Crm1 dimer (in grey, with RanGTP in light brown and NES-binding sites in yellow), thereby tuning nuclear export activity. Coordinates of the Crm1-RanGTP dimer are from [@bib5a].**DOI:** [http://dx.doi.org/10.7554/eLife.04120.018](10.7554/eLife.04120.018)

The function of Rev in RNA export is well defined, and the arrangement of Crm1 export complexes provides one clear example in which RNA organizes the Rev oligomer into a functionally important state. The 'jellyfish' model depicts Rev hexamers to be associated with the RNA on one side of the protein and NESs that recruit Crm1 export receptors on the other side ([@bib13]). Recent structural studies show that the Rev-RRE complex binds a Crm1 dimer utilizing two NES-binding pockets positioned for Rev recognition ([@bib5a]). This study also shows that the RRE plays an important role in assembly of the export complex by enhancing the affinity of the Rev oligomer for Crm1, probably by using the RNA scaffold to organize the Rev subunits and increase the local concentration of NES peptides for Crm1 binding. Additionally, SAXS studies of the RRE ([@bib17]) and SHAPE-seq analysis of Rev-RRE assembly ([@bib2]) reveal that the RNA is compact and pre-ordered to bind Rev. Consequently, it may be inferred that changes to the RRE scaffold can affect the overall arrangement of Rev subunits and redistribute the spatial availability of NESs for Crm1 recruitment and nuclear export ([Figure 5B](#fig5){ref-type="fig"}). Multiple studies support this hypothesis: (1) Resistance to a dominant negative mutant of Rev with a defective NES arose through two mutations in the RRE that changed the RNA structure but not Rev multimerization ([@bib29]), consistent with an RNA-guided reorganization of Rev oligomers. (2) Conversely, Rev complexes formed with simple repeats of the IIB hairpin displayed high RNA-binding affinity but did not recapitulate full export activity ([@bib50]), indicating that the specific RRE architecture properly arranges the Rev oligomer for function. (3) A study of cognate Rev-RRE pairs from HIV-infected patients found that mutations in the RRE were responsible for changes in activity as the pairs evolved during the course of infection ([@bib48]), suggesting that small changes in RRE sequence can alter the architecture of the Rev-RRE complex to tune its functional output. Previous studies likened the RRE to a molecular rheostat, where it is sensitive to the intracellular Rev concentrations and export activity adjusts accordingly ([@bib34]). It appears now that RRE can also perform as a structural/evolutionary rheostat, where changes to RRE structure during the course of infection can rearrange the Rev oligomer and tune the levels of nuclear export. It will be interesting to determine if interactions with other host proteins exploit the Rev-RRE oligomer in other ways.

Materials and methods {#s4}
=====================

Protein expression and purification {#s4-1}
-----------------------------------

We used a Rev 1--70 dimer construct harboring the higher-order oligomerization-disrupting mutations, Leu12Ser and Leu60Arg ([@bib13]), and a Glu47Ala surface-entropy reducing mutant ([@bib20]) for initial crystallization screens. We note that position 47 in most HIV-1 Rev isolates already is alanine, unlike the Glu47 found in HIV strain HXB3. Rev protein was expressed in *Escherichia coli* BL21 (DE3) with an N-terminal hexa-histidine tag and GB1 solubility-enhancing domain and purified using Ni affinity chromatography essentially as described ([@bib11]). However, instead of using RNAses to eliminate contaminating endogenous *E. coli* RNA that co-purifies with Rev, we added NaCl to 2 M and urea to 1 M to the cleared lysate ([@bib35]) and incubated for 1--2 hr at 4°C while binding in batch to the Ni-NTA resin. Washes and elutions were performed as described ([@bib11]). Fractions of pure protein were pooled, concentrated to ∼0.2 mM and purified by size-exclusion using a Superdex 75 column equilibrated in 40 mM Tris pH 8.0, 0.2 M NaCl, 0.1 M Na~2~SO~4~. To remove the His-GB1 tag, protein fractions after size-exclusion were pooled and cleaved with Tev protease after adding ammonium sulfate to 0.4 M. The pure, tag-free Rev obtained was concentrated to 40--50 μM and stored at 4°C prior to complex formation with RNA.

RNA synthesis {#s4-2}
-------------

RNAs were synthesized by T7 in vitro run-off transcription from synthetic DNA templates as described ([@bib12]). Purified and annealed RNAs were lyophilized and stored at −20°C.

Crystallization {#s4-3}
---------------

Lyophilized RNAs were resuspended in water at 0.4--0.5 mM. Protein and RNA were incubated together at 1.9:1 ratio at room temperature for 30 min, concentrated to 5--6 mg/ml using an Amicon ultrafree 4 3 kDa cut-off concentrator (EMD Millipore, Billerica, MA), exchanged into crystallization buffer (10 mM HEPES pH 6.5, 50 mM KCl, 2 mM MgCl~2~) using zeba desalting columns (Thermo Fisher Scientific, Rockford, IL) and concentrated to 10--12 mg/ml. Initial screens were performed using a Mosquito robot with ProComplex and Nucleix suites (Qiagen Inc, Valencia, CA). After screening ∼35--40 Rev dimer-RNA complexes, one complex comprising the Rev dimer Glu47Ala mutant and an RNA derived from IIB40, containing a UUCG tetraloop, formed cubic crystals in several conditions with PEG 400, PEG 4000 and PEG 8000. Optimized crystals were grown using hanging drop vapor diffusion by mixing the complex at 1:1 with reservoir solution containing 50 mM MES 6.0, 50 mM KCl 1--4% PEG 4000 (for native diffraction data collection) or 50 mM sodium cacodylate pH 6.0, 5 mM MgCl~2~, 8--14% PEG 400 (for heavy atom soaking). Crystals appeared in 1--2 days and grew to their full size of 100--200 microns in 3--4 days. After 1 week, native crystals were transferred into a drop containing well solution supplemented with 5% PEG 4000. PEG 400 and PEG 4000 were added directly to the drop in small increments to a final concentration of 25% PEG 400 and 14% PEG 4000 after which the crystals were flash frozen in liquid nitrogen. Crystals grown in MES buffer failed to survive heavy atom soaks but crystals grown in 50 mM cacodylate pH 6.0, 5 mM MgCl~2~, 8--14% PEG 400 were more tolerant to heavy atom soaks although they did not diffract beyond 4.5 Å. Crystals for heavy atom soaking were transferred to a fresh drop of well solution supplemented with 5% PEG 4000 and PEG 400--25% was added to the drop in small increments. For anomalous data collection, crystals were soaked in 7.1 mM ammonium tetrathio tungstate (Hampton Research, Aliso Viejo, CA, Heavy Atom Screen M2) for 15 min before flash freezing in liquid nitrogen.

Diffraction data collection and structure determination {#s4-4}
-------------------------------------------------------

Data sets were collected at the Advanced Light Source beamline 8.3.1 at 100 K. Crystals belonged to either a tetragonal (P4~1~2~1~2) spacegroup or a cubic spacegroup (P4~1~32). Diffraction data was processed and scaled using XDS ([@bib25]). Attempts with molecular replacement using the unbound Rev dimer structure or models of Rev-IIB RNA complexes as starting models with native diffraction datasets (collected at 1.116 Å) were unsuccessful. Using single wavelength anomalous dispersion (SAD) data to 5.5 Å on a W-soaked crystal (collected at 1.2146 Å), tungstate ions were located using ShelxD, phased and density-modified using ShelxE ([@bib47]). The crystal belonged to P4~1~2~1~2 space group with three copies of the Rev dimer-RNA complex and one W site per asymmetric unit. Density for the Rev helices and RNA was very clear and Rev molecules from the Rev-dimer structure ([@bib13]) and an RNA fragment from IIB RNA NMR structure ([@bib4]) were fit into the protein and RNA densities, respectively, using rigid-body fit in Coot ([@bib16]). The resulting model was used for molecular replacement into the 3.2 Å native data in the cubic space group (P4~1~32) in Phaser ([@bib36]). Initial solutions scored poorly but the appearance of positive density near the RNA fragment at the second Rev-binding site suggested that the solution was correct. Following iterative rounds of model building of the RNA using RCrane ([@bib26]) in Coot and refinement in Phenix ([@bib1]), a second round of molecular replacement was carried out using the newly built RNA alone as the search model. This time, the solution was clear with positive density for both Rev subunits. Rev subunits were then built into the density with iterative model building and refinement. The final model had good stereochemistry and showed no Ramchandran outliers ([@bib9]). While density for most water molecules or ions was not apparent at this resolution, we could place one water molecule bridging a Rev-RNA contact. Solvent-accessible surface areas were calculated using PISA ([@bib28]) and figures were generated using PyMOL ([@bib46]).

Gel shift assays {#s4-5}
----------------

Electrophoretic mobility shift assays were performed in gel shift buffer (10 mM HEPES pH 7.5, 0.1 M KCl, 1 mM MgCl~2~, 0.5 mM EDTA, 2 mM DTT, 10% glycerol, 50 μg/ml yeast tRNA and 0.2 mg/ml BSA). Rev protein stock for RNA binding was prepared in gel shift buffer supplemented with fivefold molar excess of yeast tRNA. Rev was diluted in gel shift buffer and mixed with an equal volume of \<25 pM ^32^P-RNA. Reactions were incubated at room temperature for 15 min and loaded onto continuously running 6% (for 234 nucleotide RRE) or 10% polyacrylamide gels (0.5× TBE). Gels were run at room temperature for 60--90 min, dried and exposed to a phosphorimaging screen for \>12 hr. Bands were quantified using ImageJ ([@bib45]) and data were fit using MS Excel.

For gel shift assays using RRE and detection with SYBR Green II staining (Invitrogen), gel shift buffer contained 10 mM HEPES pH 7.5, 0.3 M KCl, 1 mM MgCl~2~, 0.5 mM EDTA, 2 mM DTT, 10% glycerol and 0.2 mg/ml BSA ([@bib17]). Rev was serially diluted and mixed with an equal volume of RRE at 125 nM, incubated for 15 min and loaded onto continuously running 6% polyacrylamide gels (0.5× TBE). Gels were run at room temperature for 1--2 hr, stained with SYBR Green II and visualized under UV light. Bands were quantified using ImageJ ([@bib45]).

Rev nuclear export activity reporter assay {#s4-6}
------------------------------------------

The pCMV-GagPol-RRE reporter construct ([@bib49]) was modified to contain the HIV-1 SF2 RRE sequence (used in biochemical assays) and was complemented in trans with pcDNA4TO-Rev-3xFlag (Invitrogen mammalian expression vector) in 293T cells by transient transfection. The optimal ratio of reporter to Rev expression plasmids was first determined to establish maximal signal under non-saturating conditions for the assay. Subsequently, 50,000 HEK 293T cells, each in 96-well microtiter plate wells, were transfected with 90 ng of reporter plasmid, 0.3 ng of Rev expression plasmid, 5 ng of an mCherry fluorochrome expression vector (to visualize transfection efficiency) and 4.7 ng of pBS carrier DNA. 48 hr after transfection, the culture supernatant was removed, the cells were lysed and intracellular p24 was quantified by ELISA. mCherry expression was consistent across all transfections at the time of cell lysis. The expression of Rev-3xFlag and GAPDH was monitored by western blot analyses using mouse α-Flag (Sigma-Aldrich Corp. St. Louis, MO) and mouse α-GAPDH (Abcam, Cambridge, MA) antibodies, respectively, followed by goat α-mouse IgG-HRP (Santa Cruz Biotechnology, Dallas, TX). HRP-bound antigens were then detected by chemi-luminescence and imaged using a BioRad ChemiDoc MP imager (Bio-Rad Laboratories, Inc. Hercules, CA). Expression levels for Rev mutants were within twofold of wild-type Rev, when normalized to GAPDH loading control, and were used to normalize the quantified p24 levels ([Figure 4B](#fig4){ref-type="fig"}).

Viral replication assays {#s4-7}
------------------------

### Generation of proviral clones {#s4-7-1}

The *rev* cDNA was relocated to the *nef* region (*nef* is dispensable for ex vivo HIV replication in SupT1 cells) ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) to facilitate mutagenesis of *rev* without affecting the overlapping *tat* or *env* reading frames.

### Cells and viruses {#s4-7-2}

The infectious molecular clone, HIV~NL4-3,~ was acquired from the NIH AIDS Reagent Program. HEK 293T cells were co-transfected with proviral plasmids and mammalian expression vectors containing HIV~NL4-3~ Rev and Tat at a ratio of 1:50 (wt/wt, mammalian expression vector:proviral plasmid) to promote robust production of viruses containing mutant Rev. Virus-laden supernatants were collected 48 hr post transfection, centrifuged at 500×*g* for 5 min, 0.45 μM-filtered, and stored in aliquots at −80°C. Virus stocks were titered using ELISA to quantify p24 viral capsid protein. Mouse monoclonal and rabbit polyclonal α-p24 antibodies used in the ELISA were obtained from the NIH AIDS Reagent Program.

### Virus spreading assay {#s4-7-3}

Sup-T1 cells (NIH AIDS Reagent Program) were cultured in RPMI media supplemented with 25 mM HEPES pH 7.4, 10% heat-inactivated fetal calf serum (Hyclone, Waltham MA), and 1% penicillin/streptomycin. 10^6^ Sup-T1 T-cells were inoculated with 2.5 ng p24 in 250 μl media containing 1 μg/ml PEI and 8 μg/ml polybrene in 96-well flat bottom polystyrene cell culture microplates and then centrifuged for 2 hr at 1200×*g* at 37°C. Each virus was assayed in biological triplicate. Input virus was then removed via washing cells twice with 250 μl phosphate-buffered saline (PBS). Cells were resuspended in 250 μl of media and incubated at 37°C, 5% CO~2~. Under these centrifugal inoculation conditions, the multiplicity of inoculation (MOI) is approximately 0.05--0.025 as determined by acute infection of Sup-T1 T-cells with serial dilutions of HIV~NL4-3~ expressing green fluorescent protein (GFP) followed by flow cytometry to quantify the GFP-expressing population. The infections were monitored every 48 hr following inoculation by immunofluorescence assay to detect cellular HIV antigen synthesis and by HIV p24 ELISA on the culture supernatant to quantify virus release. The infections were monitored until robust HIV cytopathic effect (cell necrosis and syncytia formation) was observed in the wild-type virus control.

Protein subcellular localization and RNA fluorescence in situ hybridization (FISH) assays {#s4-8}
-----------------------------------------------------------------------------------------

HeLa cells (150,000) cultured on 12 mm poly-L-lysine coated glass coverslips were acutely infected with 100 ng p24 of HIV pseudotyped with VsV-G envelope glycoprotein and containing 3x-flag epitope-tagged Rev in the *nef* locus in DMEM media containing 8 μg/ml polybrene. These inoculation conditions equate to an effective MOI of 1.0--0.5 as determined previously via TCID~50~ determination in HeLa cells.

24 hr post inoculation, the cells were washed twice with PBS, fixed in 4% paraformaldehyde/PBS for 10 min at RT, washed in 0.15 M glycine/PBS, permeabilized with 0.5% Triton X-100/PBS, and then blocked with 1% bovine serum albumin (BSA)/PBS/0.1% Tween-20 at 37°C for 1 hr. Antigens were then probed with a 1:250 dilution (vol/vol) of rabbit polyclonal α-HIV p24 (NIH AIDS Reagent Progam) and a 1:500 dilution of mouse α-flag (Sigma) in 1% BSA/PBS/0.1% Tween-20 at 37°C for 1 hr. The cells were washed twice with PBS/0.1% Tween-20 and then probed with a 1:250 dilution of goat α-rabbit IgG-rhodamine (MP Biomedicals, LLC, Santa Ana, CA), a 1:500 dilution of goat α-mouse IgG-FITC (MP Biomedicals) and 100 ng/ml DAPI nuclear stain. The cells were washed three times with PBS/0.1% Tween-20 and the coverslips were mounted to glass slides using Vectashield hardset mounting media for fluorescence. Cells were imaged using a 63×, 1.3 NA Leica objective and a Hamamatsu C4742-12 cooled CCD camera on a Leica DMI6000B stand. 25 z-stack images were taken using exposures normalized to the brightest sample, background-subtracted, and then merged to a single image using the brightest point projection method in the Volocity imaging software suite (Perkin Elmer, Waltham, MA).

For RNA subcellular localization by FISH, acutely infected HeLa cells were fixed with methanol for 10 min at RT and rehydrated in 2× SCC/10% formamide at 37°C for 10 min. They were then probed using Stellaris probe sets (Biosearch) targeting HIV-1 *gag* nt790--2292 conjugated to Quasar570 dye and HIV-1 *nef* nt8787--9407 conjugated to Quasar670 dye at 125 nM in 2× SCC/10% formamide/100 mg/ml dextran sulfate for 2 hr at 37°C. The total HIV-1 RNA probe set included 39 unique DNA oligonucleotides and the HIV-1 gag RNA probe set included 48 unique DNA oligonucleotides each computationally predicted to bind specifically to their target sequence (Biosearch Stellaris FISH Probe Designer web-based program). Following incubation, 2 ml of 2× SCC/10% formamide was added and incubated for 30 min at 37°C to dissociate nonspecifically bound probe. The wash was aspirated, and 1 ml of 2× SCC/10% formamide containing 100 ng DAPI nuclear stain was added and incubated at 37°C for 30 min. The cells were then washed twice with 2× SCC, coverslips mounted to glass slides, and cells were imaged with brightness and contrast adjusted using the same linear parameters for all images.

Accession codes {#s4-9}
---------------

Atomic coordinates and structure factors for the Rev dimer-RRE crystal structure have been deposited in the Protein Data Bank under the accession code 4PMI.
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Thank you for sending your work entitled "RNA-directed remodeling of the HIV--1 Rev oligomer orchestrates Rev-RRE assembly" for consideration at *eLife*. Your article has been favorably evaluated by John Kuriyan (Senior editor), Wesley Sundquist (Reviewing editor), and 2 reviewers, one of whom, Jamie Williamson, agreed to reveal his identity.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

Jayaraman et al. present a 3.2 A resolution crystal structure of a Rev dimer bound to a fragment of RNA corresponding to the high-affinity binding site (Stem loop IIB) of the Rev-response element (RRE) plus the adjacent IIABC junction. In order to crystallize the complex, the authors used a Rev construct in which two residues were mutated at one of the hydrophobic oligomerization interfaces, promoting formation with only a Rev dimer. While dimerization of Rev occurs using the same hydrophobic interfaces as previously reported, the structure reveals that the Rev dimer binds the RNA with a crossing angle that is much more acute than was previously shown in the dimer in the absence of RNA (50 deg vs. 120-140 deg.). The authors suggest that this degree of freedom (different crossing angles) may be exploited in the formation of higher order complexes. Strong biochemical and molecular virological analyses are presented in support of the structure.

The crystal structure is the first example of a high resolution structure of a Rev dimer-RNA complex, despite considerable efforts over two decades, and is thus an important advance. Important new contributions include: 1) the discovery that the crossing angle and hydrophobic interface of the Rev dimer can change quite dramatically (∼70 degrees) in response to RNA binding, which allows the two ARM helices to bind in adjacent major grooves of the RNA, and 2) the definition of a new Rev-RNA binding mode (seen for the Rev-RNA Junction site), which may represent the second step in cooperative assembly of Rev with the RRE. The manuscript is clear and well written, and the descriptions of the structure are very lucid. The study is of high technical quality, reveals remarkable molecular flexibility in both the Rev protein configuration and its RNA interactions, and represents an important advance in our understanding of the molecular basis for HIV-1 RNA export. This and the accompanying manuscript describing the EM of a Crm1 dimer bound to Rev-RRE are the most significant advance in this important story for many years.

Major issues (which must be addressed by the authors):

This work provides the most advanced structural framework for thinking about how the Rev-RRE export complex is assembled. No additional experiments need to be performed, but the text should be modified to put the observations into better context and to address the specific issues highlighted below.

1\) There are now three different arrangements of the Rev dimer that have been observed, and surely there is interesting, and perhaps confounding, structural plasticity of the Rev dimer interface. This plasticity is portrayed as being a "strategy" of the virus, but the possibility that one or more of the in vitro structures may not reflect functional complexes. The manuscript skirts around this issue, and does not really address how to build the present complex into a functional Rev RRE complex, or how all of the structures may or not be consistent with that functional complex.

2\) The authors should also discuss how well the junction serves as a proxy for the junction in the viral Stem II. In particular, Stem IIA is almost certainly an A-form helix that must merge into the junction, which is only two nucleotides in the crystallized construct. It is possible that the native Stem II RNA has a different conformation, and that the plasticity of the Rev-RRE interface has allowed crystallization of a non-native conformation.

3\) There is no conclusive evidence that a second molecule of Rev binds to stem IIC in the context of the larger RRE, and the data in [Figure 2](#fig2){ref-type="fig"}, panels (d) and (e) provide little support since a mutation that is absolutely required for dimerization in the Stem II40 RNA has little to no discernable effects in the context of the larger RNA. While the authors argue that, in the context of a larger RNA, this mutation\'s effects can be overcome is an interesting idea, there is no actual evidence. A simpler explanation is that the complex uses a different pathway for oligomerization, or even that multiple pathways exist, and if one pathway is blocked then another can be readily utilized. The authors should address this issue more directly or present data showing that the observed complex is truly a part of the oligomerization pathway.

4\) Another issue that needs to be addressed more directly is how the present structure fits into the Rev hexamer structure and the previously described jellyfish model. Is it possible to accommodate the second Rev-Rev interface seen in the Rev-only crystal structure with the Rev dimer conformation seen in the present structure? Is it possible to envision a plausible hexamer structure in the context of RNA with the present dimer interface?

5\) The Wang lab at NIH has proposed a specific conformation of a Rev-RRE complex based on SAXS data. How does the present structure fit into that model?

6\) The final figure is problematic. It is certainly fine to speculate, but while it is formally plausible that the RRE may guide Rev into an array of dimers with multiple crossing angles upon protein-RNA contact, there is as yet no experimental basis for this and the hexamers modeled here are entirely speculative. It is equally plausible, for example, that crossing angles similarly acute to the one reported herein are ubiquitously used for RNP assembly, with larger angles used for interaction with other host-cell proteins (or other variations on the same theme). This figure should be deleted or, alternatively, replaced with a figure that explains the authors' current general model, particularly in light of the accompanying Crm1 dimer structure.

Other issues for the authors\' consideration:

1\) Title. Change "Rev oligomer" to "Rev dimer". Throughout the manuscript there should be careful usage of "Rev oligomer", which, in at least some places here and in the accompanying manuscript, is alluding to (at least) a hexamer, and in other places to a Rev dimer. Say "dimer" when "dimer" is meant. Similarly, we suggest sticking to the term "subunit" when a single polypeptide chain is meant and not alternating with "molecule". A dimer is also a molecule.

2\) Final sentence of the Abstract: "our studies support an RRE-directed Rev oligomer assembly, where RRE utilizes the inherent plasticity of Rev interfaces and optimally positions Rev subunits to match the architecture of the Crm1 export complex". Omit. There is nothing here about Crm1 nor about a Rev oligomer larger than a dimer.

3\) The three mutations in the crystallized Rev construct should be indicated in [Figure 1](#fig1){ref-type="fig"}. The position of the oligomerization-inhibiting mutations should be indicated on the structure.

4\) [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} shows gel shift assays of Rev with RRE-Stem II and IIB40. It is clear the RNA below is a single species. However, the first observed shift shows a doublet band in the IIB40, and a smeared/fuzzy band in stem II. The authors should note this somehow as these are both evidence of conformational heterogeneity within their samples (the first being the presence of two stable conformations and the second a constant switching between two conformations). Further this doublet nature appears to be resolved upon the second Rev binding, indicating a resolving of this phenomenon.

5\) The authors use a 240 nt RRE. They should state that the full RRE is ∼351 nt, and the smaller construct has been shown to be proficient, though not optimal, in nuclear export.

6\) The Rev ARM-RNA IIB RRE interface generally agrees well with the analogous interface presented in the 1996 Battiste et al. NMR structure, but the crystal interface is described as being subtly different in detail. It seems equally likely, however, that the solution structure simply lacked precision, particularly given the state of NMR structural studies at that time. This should probably be acknowledged explicitly (or, if the authors wish to make a point of the differences, they should show that their current structure is incompatible with the earlier NMR data).

7\) Figure 2C--figure supplement 1 is not useful in its current form. The intent seems to be to demonstrate more clearly than in [Figure 2E](#fig2){ref-type="fig"} a binding defects for Rev-Q51A. However, the effects are modest and it is nearly impossible for the reader to draw any conclusions from the data presented.

8\) The authors should show the raw western blots that underlie the normalized data in [Figure 4C](#fig4){ref-type="fig"}. The results seem clear enough, but it is important to show that the Rev mutations do not destabilize the protein significantly, and this information is lost through the normalization procedure.

9\) "... enables a virus with limited coding capacity to build a large, asymmetric RNP using a small, homooligomeric protein to achieve unprecedented structural and functional complexity." This is really just hype, given that the structure of the large asymmetric RNP is not known nor is its structural and functional complexity.
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Author response

*Major issues (which must be addressed by the authors)*:

*1) There are now three different arrangements of the Rev dimer that have been observed, and surely there is interesting, and perhaps confounding, structural plasticity of the Rev dimer interface. This plasticity is portrayed as being a "strategy" of the virus, but the possibility that one or more of the in vitro structures may not reflect functional complexes. The manuscript skirts around this issue, and does not really address how to build the present complex into a functional Rev RRE complex, or how all of the structures may or not be consistent with that functional complex*.

While we share the reviewers' concern that one or more of the in vitro structures may not reflect functional complexes, we note that:

All structures solved so far (including ours) have required some modification of the Rev-RRE system to enable structure determination, owing to the biochemical behavior of the system. Nevertheless, they are consistent with a large body of mutational data and functional assays and consequently are unlikely to represent irrelevant trapped states.

Our Rev-dimer/RNA configuration may be a part of the fully assembled functional complex or could represent a potential assembly intermediate. In either case, the structure illustrates the direct coupling between oligomerization and RNA binding towards cooperative assembly. The central finding of the paper, plasticity of Rev dimer interface, explains several intriguing observations in the literature (Discussion section) and connects the RNA architecture, which is a function of a continually evolving RNA sequence, to Crm1-dependent nuclear export activity and HIV replication (elaborated in the Discussion section). In fact, it will be interesting to capture Rev in other conformational states with RNA or other protein partners to observe the extent of plasticity both in this dimer interface and the second hydrophobic interface.

The present complex can be built into a full Rev/RRE complex based on the jellyfish model ([Figure 5](#fig5){ref-type="fig"}), although it is difficult to determine whether or not this is a functional complex. Our responses to other issues below are also applicable here.

*2) The authors should also discuss how well the junction serves as a proxy for the junction in the viral Stem II. In particular, Stem IIA is almost certainly an A-form helix that must merge into the junction, which is only two nucleotides in the crystallized construct. It is possible that the native Stem II RNA has a different conformation, and that the plasticity of the Rev-RRE interface has allowed crystallization of a non-native conformation*.

We recognize that stem IIA, which very likely is an A-form helix, is only two nucleotides in our construct. Several lines of evidence suggest that the junction site is a good proxy for the junction in the RRE stem II:

The position of helix disruptions adjacent to the IIB site is critical in determining Rev oligomerization and affinity ([@bib58]). A disruption that matched the position of the stem II junction relative to IIB site had the highest affinity and most efficient Rev oligomerization. Furthermore, although Rev was able to dimerize on an RNA containing any helix disruption positioned next to IIB, the exact sequence of the junction site, as it is in IIB40, displayed the highest affinity and cooperativity, comparable to RRE-stem II ([@bib12]) ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}). Additionally, the reviewers pointed out a doublet/fuzzy band at the first observed shift in both IIB40 and stem II RNA, while the free RNAs and the Rev-dimer-bound RNAs migrate as single species.

This conformational heterogeneity in both RNAs in the Rev-monomer-bound species suggests similar binding patterns for both the RNAs. We have modified our manuscript in the first paragraph of the Results section under the title: Rev dimer-RRE structure and [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} to reflect these points.

DMS probing ([@bib8]) and SHAPE-seq ([@bib2]) studies on Rev-RRE complexes show melting of an AU base-pair from stem IIA at the junction, with G76 potentially base-pairing with the A from the melted base-pair upon Rev binding ([@bib3]). Consistent with these studies, we observe in our structure that G76 indeed base pairs with A44 (corresponding to A from the melted base pair) and not A42 (see the Results section: Diversity of RNA recognition by the Rev ARM).

As the reviewers point out, stem IIA most likely is an A-form helix that must merge into the junction. We have now included a figure ([Figure 3--figure supplement 3](#fig3s3){ref-type="fig"}) and corresponding text in the manuscript (in the Results section) under "Diversity of RNA recognition by the Rev ARM" to address this point. We have placed an A-form helix adjacent to the junction site, where it is likely to merge. Its position approximately determines where the remaining RRE is likely to be. If the second Rev subunit were to use its other hydrophobic interface to recruit a third Rev subunit, the ARM of the third Rev subunit would be positioned to contact the RRE, although it is possible that this interface is also plastic and could be further remodeled by the RRE.

The evidence that the junction site serves as a proxy for the RRE stem II junction is substantial, but we cannot formally rule out that its configuration differs in the context of stem IIA. Nonetheless, the basic inferences drawn from our structure, i.e. plasticity of the Rev dimer interface and the importance of the site architecture for Rev binding with few base-specific contacts, are unlikely to change.

*3) There is no conclusive evidence that a second molecule of Rev binds to stem IIC in the context of the larger RRE, and the data in* [*Figure 2*](#fig2){ref-type="fig"}*, panels (d) and (e) provide little support since a mutation that is absolutely required for dimerization in the Stem II40 RNA has little to no discernable effects in the context of the larger RNA. While the authors argue that, in the context of a larger RNA, this mutation\'s effects can be overcome is an interesting idea, there is no actual evidence. A simpler explanation is that the complex uses a different pathway for oligomerization, or even that multiple pathways exist, and if one pathway is blocked then another can be readily utilized. The authors should address this issue more directly or present data showing that the observed complex is truly a part of the oligomerization pathway*.

These comments are related to issue (2) above, and we have made changes to the Results section under: The Rev dimer rearranges upon RNA binding, to clarify the issue and raise alternative possibilities. There are at least three explanations for the observations in [Figure 2d and 2e](#fig2){ref-type="fig"}:

In the context of the full length RNA, the effect of a Q51A mutation can be overcome by other compensating interactions.

As the reviewers suggest, there could be multiple pathways for oligomerization and that if one pathway is blocked, then another can be utilized.

The observed complex is not truly part of the oligomerization pathway.

4\) Another issue that needs to be addressed more directly is how the present structure fits into the Rev hexamer structure and the previously described jellyfish model. Is it possible to accommodate the second Rev-Rev interface seen in the Rev-only crystal structure with the Rev dimer conformation seen in the present structure? Is it possible to envision a plausible hexamer structure in the context of RNA with the present dimer interface?

The present structure can be used to form a Rev hexamer model, similar to the previously described jellyfish model, albeit with a different overall architecture. [Figure 5](#fig5){ref-type="fig"}, which has now been modified, depicts some plausible hexamer models that use different combinations of both the present dimer interface and the RNA-free dimer interface connected by the second Rev-Rev interface.

5\) The Wang lab at NIH has proposed a specific conformation of a Rev-RRE complex based on SAXS data. How does the present structure fit into that model?

Our model from [Figure 3--figure supplement 3A](#fig3s3){ref-type="fig"}, when placed into the SAXS envelope of the RRE, is consistent with the Wang lab's overall map of RRE structural elements ([@bib17]; [Figure 3--figure supplement 3B and 3C](#fig3s3){ref-type="fig"}, and also described in the Results section under: "Diversity of RNA recognition by the Rev ARM"). Their specific model proposes that stems IIB and IA template Rev assembly on the RRE and bridge the arms of the 'A' shaped RRE structure. However, DMS probing ([@bib8]) and SHAPE-seq experiments ([@bib2]) indicate that Rev assembly nucleates at stem IIB and proceeds via stem II along the length of stem I, implying that Rev-binding at IA occurs after Rev binding to IIB and the stem II junction. Thus, our structure is consistent with the RRE chemical probing studies but does not support the specific model of an initial Rev-dimer assembling at IIB and IA. Our structure supports a more general model where the RRE topology and major groove spacing sets the arrangement of Rev oligomers, which could bridge the two arms of the RRE 'A' structure.

*6) The final figure is problematic. It is certainly fine to speculate, but while it is formally plausible that the RRE may guide Rev into an array of dimers with multiple crossing angles upon protein-RNA contact, there is as yet no experimental basis for this and the hexamers modeled here are entirely speculative. It is equally plausible, for example, that crossing angles similarly acute to the one reported herein are ubiquitously used for RNP assembly, with larger angles used for interaction with other host-cell proteins (or other variations on the same theme). This figure should be deleted or, alternatively, replaced with a figure that explains the authors' current general model, particularly in light of the accompanying Crm1 dimer structure*.

We agree that the figure showed too much detail given the speculative arrangements of Rev hexamers. The intent of the figure is to highlight plausible hexamer models whose actual architecture would depend on the scaffolding RNA or host-cell proteins. To clarify, we have modified the figure as suggested to connect RNA structure and Rev plasticity with Crm1 recruitment, in light of the Crm1 dimer structure.

*Other issues for the authors\' consideration*:

*1) Title. Change "Rev oligomer" to "Rev dimer". Throughout the manuscript there should be careful usage of "Rev oligomer", which, in at least some places here and in the accompanying manuscript, is alluding to (at least) a hexamer, and in other places to a Rev dimer. Say "dimer" when "dimer" is meant. Similarly, we suggest sticking to the term "subunit" when a single polypeptide chain is meant and not alternating with "molecule". A dimer is also a molecule*.

We have made the suggested changes and changed the title according to the journal request. The title now is: "RNA-directed remodeling of the HIV--1 protein Rev orchestrates assembly of the Rev-Rev response element complex".

*2) Final sentence of the Abstract: "our studies support an RRE-directed Rev oligomer assembly, where RRE utilizes the inherent plasticity of Rev interfaces and optimally positions Rev subunits to match the architecture of the Crm1 export complex". Omit. There is nothing here about Crm1 nor about a Rev oligomer larger than a dimer*.

We have made the suggested change.

*3) The three mutations in the crystallized Rev construct should be indicated in* [*Figure 1*](#fig1){ref-type="fig"}*. The position of the oligomerization-inhibiting mutations should be indicated on the structure*.

We have indicated the mutations in [Figure 1](#fig1){ref-type="fig"} and [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

*4)* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"} *shows gel shift assays of Rev with RRE-Stem II and IIB40. It is clear the RNA below is a single species. However, the first observed shift shows a doublet band in the IIB40, and a smeared/fuzzy band in stem II. The authors should note this somehow as these are both evidence of conformational heterogeneity within their samples (the first being the presence of two stable conformations and the second a constant switching between two conformations). Further this doublet nature appears to be resolved upon the second Rev binding, indicating a resolving of this phenomenon*.

We have noted this in the legend for [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

*5) The authors use a 240 nt RRE. They should state that the full RRE is ∼351 nt, and the smaller construct has been shown to be proficient, though not optimal, in nuclear export*.

We have included this information in the Introduction section.

*6) The Rev ARM-RNA IIB RRE interface generally agrees well with the analogous interface presented in the 1996 Battiste et al. NMR structure, but the crystal interface is described as being subtly different in detail. It seems equally likely, however, that the solution structure simply lacked precision, particularly given the state of NMR structural studies at that time. This should probably be acknowledged explicitly (or, if the authors wish to make a point of the differences, they should show that their current structure is incompatible with the earlier NMR data)*.

As suggested, we indicate that the solution structure solved nearly two decades ago may have lacked precision (see Results section under: "Diversity of RNA recognition by the Rev ARM") and does not suggest experimental differences with the current structure.

*7) Figure 2C--figure supplement 1 is not useful in its current form. The intent seems to be to demonstrate more clearly than in* [*Figure 2E*](#fig2){ref-type="fig"} *a binding defects for Rev-Q51A. However, the effects are modest and it is nearly impossible for the reader to draw any conclusions from the data presented*.

The purpose of the figure is to show that although the binding defect of Q51A is modest, it is observed in two different assays: one using stoichiometric amounts of Rev and RRE ([Figure 2D and 2E](#fig2){ref-type="fig"}) and the other with Rev in vast excess of the RRE ([Figure 2--figure supplement](#fig2s1){ref-type="fig"}). Hence, the observed defect is modest but real. We have clarified this in the Results section under: "The Rev dimer rearranges upon RNA binding".

*8) The authors should show the raw western blots that underlie the normalized data in* [*Figure 4C*](#fig4){ref-type="fig"}*. The results seem clear enough, but it is important to show that the Rev mutations do not destabilize the protein significantly, and this information is lost through the normalization procedure*.

We presume the reviewer was referring to western blots for [Figure 4B](#fig4){ref-type="fig"}, not for the replication time course of [Figure 4C](#fig4){ref-type="fig"}, and these data are now included. Data were normalized both to Rev and GAPDH expression levels.

*9) Page 9. "... enables a virus with limited coding capacity to build a large, asymmetric RNP using a small, homooligomeric protein to achieve unprecedented structural and functional complexity." This is really just hype, given that the structure of the large asymmetric RNP is not known nor is its structural and functional complexity*.

We have modified the sentence.

[^1]: Statistics for the highest-resolution shell are shown in parentheses.
